HCW Biologics (HCWB) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free HCWB Stock Alerts $1.20 +0.04 (+3.45%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHCW Biologics Inc. (NASDAQ:HCWB) Short Interest Updatemarketbeat.com - April 2 at 9:38 AMHCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023investorplace.com - April 2 at 12:01 AMHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlightsglobenewswire.com - April 1 at 4:10 PMHCW Biologics Inc. (NASDAQ:HCWB) Sees Large Growth in Short Interestmarketbeat.com - March 12 at 5:17 PMRebecca Byam Bought 122% More Shares In HCW Biologicsfinance.yahoo.com - February 24 at 11:28 AMSeveral Insiders Invested In HCW Biologics Flagging Positive Newsfinance.yahoo.com - January 25 at 10:30 AMHCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment Opportunitymarkets.businessinsider.com - November 17 at 8:25 AMAnalysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)markets.businessinsider.com - November 15 at 9:51 AMHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlightsfinanznachrichten.de - November 14 at 11:10 PMHCW Biologics GAAP EPS of -$0.14, revenue of $174.77Mmsn.com - November 14 at 1:10 PMHCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlightsfinance.yahoo.com - November 14 at 8:10 AMADMA Biologics Inc ADMAmorningstar.com - November 11 at 10:48 PMHCW Biologics Inc HCWBmorningstar.com - November 11 at 10:48 PMPromising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW Biologicsmarkets.businessinsider.com - November 11 at 2:04 AMInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meetingfinance.yahoo.com - November 8 at 10:42 AMSamsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companiesfinance.yahoo.com - November 6 at 9:07 PMMasonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meetingfinance.yahoo.com - November 1 at 11:40 AMHCW Biologics director Gary Winer buys shares worth $3.3k - filingseekingalpha.com - September 21 at 12:33 AMInsider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Incfinance.yahoo.com - September 16 at 3:20 PMInsider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Incfinance.yahoo.com - September 9 at 5:33 PMHCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023finance.yahoo.com - September 6 at 7:21 PMInsider Stock Buying Reaches US$845k On HCW Biologicsfinance.yahoo.com - August 18 at 6:23 AMAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Cochlear Limited (OtherCHEOF)markets.businessinsider.com - August 15 at 9:04 AMHCW Biologics, Inc: HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - August 11 at 4:33 PMAnalysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Arrowhead Pharmaceuticals (ARWR)markets.businessinsider.com - August 11 at 4:33 PMHCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlightsfinance.yahoo.com - August 11 at 4:33 PMThe past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitablefinance.yahoo.com - July 7 at 9:49 AMHCWB - HCW Biologics Inc.finance.yahoo.com - July 1 at 11:47 PMDirector at HCW Biologics Acquires Company Stock Options Worth 12,500 Sharesbenzinga.com - June 16 at 12:31 PMHCW Gains on Patent Newsbaystreet.ca - June 14 at 12:46 PMHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorderstechnews.tmcnet.com - June 14 at 7:45 AMHCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disordersfinance.yahoo.com - June 14 at 7:45 AMChief Financial Officer of HCW Biologics Purchased $51K In Stockbenzinga.com - June 9 at 6:28 PMHCW Biologics Chief Financial Officer Trades Company's Stockbenzinga.com - June 8 at 12:23 PMAnalysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS) and HCW Biologics (HCWB)markets.businessinsider.com - May 10 at 7:54 PMHCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)finance.yahoo.com - May 10 at 9:52 AM10-Q: HCW BIOLOGICS INC.marketwatch.com - May 9 at 11:13 PMRecap: HCW Biologics Q1 Earningsmsn.com - May 9 at 1:10 PMHCW Biologics: Q1 Earnings Insightsmsn.com - May 9 at 1:10 PMHCW Biologics, Inc: HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlightsfinanznachrichten.de - May 9 at 8:10 AMHCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlightsfinance.yahoo.com - May 9 at 8:10 AMHCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loanfinance.yahoo.com - April 27 at 7:57 AMEF Hutton Reiterates HCW Biologics (HCWB) Buy Recommendationmsn.com - April 19 at 6:39 PMHCW Biologics Poster Presentation at AACR Annual Meeting 2023finance.yahoo.com - April 13 at 10:46 AMHCW Biologics, Inc: A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseasesfinanznachrichten.de - April 5 at 3:13 PMMaxim Group Remains a Buy on HCW Biologics (HCWB)markets.businessinsider.com - April 5 at 10:12 AMA Novel Immunotherapeutic Approach to Treating Aging-Associated Diseasesfinance.yahoo.com - April 3 at 10:12 AMHCW Biologics (HCWB) Receives a Buy from Maxim Groupmarkets.businessinsider.com - March 31 at 12:14 PMHCW Biologics, Inc: HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 29 at 7:29 PMJonesTrading Reaffirms Their Buy Rating on HCW Biologics (HCWB)markets.businessinsider.com - March 29 at 1:49 PM Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. HCWB Media Mentions By Week HCWB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼0.000.36▲Average Medical News Sentiment HCWB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼00▲HCWB Articles Average Week Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eagle Pharmaceuticals News Today Equillium News Today BioLineRx News Today Lantern Pharma News Today Clene News Today Reneo Pharmaceuticals News Today Checkpoint Therapeutics News Today Immix Biopharma News Today Gain Therapeutics News Today Celularity News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCWB) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.